Mark Cuban backs Trump’s prescription drug executive order: ‘Here to help’

The National Director of Health Institutes, Dr. Jay Bahtasharia, is discussing president Donald Trump procedures to reduce the prices of prescribed medicines and his priorities for the agency.
On Wednesday, business leader Mark Koban expressed his support for President Donald Trump’s executive on health care and drug prices despite his long -term opposition to many of the President’s policies.
“The executive order of the Trump administration issued earlier in the week may lead to a large saving in the costs of prescribed medicines,” Shark Tank Cuban, who founded the Cost Plus Plus pharmaceutical company in 2022 as a company of public advantages to reduce public medicines, said that the executive order of the Trump administration issued earlier in the week could lead to a large saving in the costs of prescribed medicines.
“You should be honest. Realdonaldtrump Eo on health care and in particular, drug pricing can provide hundreds of billions,” Kobe wrote in a post on X.
Six policies believed to lead to these savings have made it clear by changing how drug makers and pharmacy directors interact (PBMS) and fishermen to provide consumer funds for their drugs.
Mark Kobe launches a pharmacy online, claiming to be “radical transparent”

Businessman Mark Kobe praised President Trump’s health care arrangement and called for more prescribed medicine repairs. (Photo by Stephen Ferddman / Getty Emoxz / Getty Em.
Kobe said that the divorce of formulas from PBMS requires independent groups without an economic incentive of recipes to develop them will end the discounts and allow a net pricing for prescribed medicines.
He also said that PBMS should be required to submit claim data to employers, states and manufacturers, as manufacturers will have to have to pay for them and allow them to reduce retail prices.
Kobe called for the end of the specialized level of medicines and the purchase condition from a specific pharmacy, saying that there is nothing “nothing special about specialized drugs” and this appointment is used mainly to “raise the price.”
Mark Cuban asked about the whereabouts of everything, “with a mistake,” with Trump: “The Business President”

Cuban has criticized President Trump since his candidacy for positions in 2016. (Andy Manis / Getty Images / Getty Images)
In addition, Cuban suggested that all pharmacies must be fully compensated for brand medicines and that the general cost rate should be eliminated because it “allows distributors to raise prices on genetic drugs with the threat of fees and more fees.”
Other policies called by the Cubans were to remove the conditions of confidentiality that prevent companies from speaking to manufacturers, which are believed to lead to better prices and well -being plans for patients, as well as to end the vital replacement calls to ensure a less expensive option without replacing PBMS with a more expensive version.
“I put me in the coach, I am here to help.”
Trump reveals the next industry that will face a “major” imminent tariff

President Trump orders regulatory reforms in health and pharmaceutical industries. (Getty Images / Getty Images)
The Executive Order of the Trump Department of the Federal Agencies to develop a variety of regulations and reports related to healthcare and prescribed medicines, including reviews of the drug price negotiation program under the Act of Inflation and the stability of the DICARE premiums.
It also directed the development of regulations aimed at reducing high -cost drug prices for the elderly under medical care, including drugs that are not part of the price negotiation program; Medicaid drug payment program review; It is made of life -saving drugs such as insulin or ebeniferne more affordable at reasonable prices.
Get Fox Business on the Go by clicking here
The executive order calls for reports to re -evaluate the role of brokers in the pharmaceutical value chain to increase competition and reduce the prices of medicines, which makes medicines with high -cost medical prescriptions more competitive, and enhance the imports of prescribed drugs to reduce prices “without sacrificing safety or quality”.
Don’t miss more hot News like this! Click here to discover the latest in Business news!
2025-04-17 19:48:00